28 related articles for article (PubMed ID: 18630461)
1. MHC2TA is associated with rheumatoid arthritis in Japanese patients.
Iikuni N; Ikari K; Momohara S; Tomatsu T; Hara M; Yamanaka H; Okamoto H; Kamatani N
Ann Rheum Dis; 2007 Feb; 66(2):274-5. PubMed ID: 17090564
[No Abstract] [Full Text] [Related]
2. Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transactivator (CIITA) in systemic lupus erythematosus.
Koizumi K; Okamoto H; Iikuni N; Nakamura T; Kawamoto M; Momohara S; Ichikawa N; Furuya T; Kotake S; Taniguchi A; Yamanaka H; Kamatani N
Ann Rheum Dis; 2005 Jun; 64(6):947-50. PubMed ID: 15897313
[TBL] [Abstract][Full Text] [Related]
3. A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus.
Linga-Reddy MV; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Nordmark G; Rönnblom L; Alarcón-Riquelme ME
Tissue Antigens; 2007 Nov; 70(5):412-4. PubMed ID: 17711409
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II transactivator gene polymorphism: associations with Löfgren's syndrome.
Grunewald J; Idali F; Kockum I; Seddighzadeh M; Nisell M; Eklund A; Padyukov L
Tissue Antigens; 2010 Aug; 76(2):96-101. PubMed ID: 20230522
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA).
Patarroyo JC; Stuve O; Piskurich JF; Hauser SL; Oksenberg JR; Zamvil SS
Genes Immun; 2002 Feb; 3(1):34-7. PubMed ID: 11857059
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality.
Lindholm E; Melander O; Almgren P; Berglund G; Agardh CD; Groop L; Orho-Melander M
PLoS One; 2006 Dec; 1(1):e64. PubMed ID: 17183695
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
Mumtaz M; Löfgren S; Hugander A; Dimberg J
Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of MHC2TA transcription in cancer.
Holling TM; van Eggermond MC; Jager MJ; van den Elsen PJ
Biochem Pharmacol; 2006 Nov; 72(11):1570-6. PubMed ID: 16879803
[TBL] [Abstract][Full Text] [Related]
9. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association.
Bronson PG; Criswell LA; Barcellos LF
Ann Rheum Dis; 2008 Jul; 67(7):933-6. PubMed ID: 17875550
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of MHC-II and CIITA genes.
Wright KL; Ting JP
Trends Immunol; 2006 Sep; 27(9):405-12. PubMed ID: 16870508
[TBL] [Abstract][Full Text] [Related]
11. Regulation of MHC class II gene expression by the class II transactivator.
Reith W; LeibundGut-Landmann S; Waldburger JM
Nat Rev Immunol; 2005 Oct; 5(10):793-806. PubMed ID: 16200082
[TBL] [Abstract][Full Text] [Related]
12. MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
Friese MA; Jones EY; Fugger L
Trends Immunol; 2005 Nov; 26(11):559-61. PubMed ID: 16139566
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
